1. High and low dose radiation effects on mammary adenocarcinoma cells – an epigenetic connection
    Lidia Luzhna et al, 2016, Oncoscience CrossRef
  2. Prospective Monitoring of Circulating Epithelial Tumor Cells (CETC) Reveals Changes in Gene Expression during Adjuvant Radiotherapy of Breast Cancer Patients
    Matthias Mäurer et al, 2021, Current Oncology CrossRef
  3. Drug screening approach combines epigenetic sensitization with immunochemotherapy in cancer
    Chiara Facciotto et al, 2019, Clinical Epigenetics CrossRef
  4. Prognostic relevance of DNA damage and repair biomarkers in elderly patients with hormone-receptor-positive breast cancer treated with neoadjuvant hormone therapy: evidence from the real-world setting
    Anna Di Benedetto et al, 2019, Therapeutic Advances in Medical Oncology CrossRef
  5. piR-39980 mediates doxorubicin resistance in fibrosarcoma by regulating drug accumulation and DNA repair
    Basudeb Das et al, 2021, Communications Biology CrossRef
  6. Metformin enhances radiation response of ECa109 cells through activation of ATM and AMPK
    Tingting Feng et al, 2015, Biomedicine & Pharmacotherapy CrossRef
  7. FASN regulates cellular response to genotoxic treatments by increasing PARP-1 expression and DNA repair activity via NF-κB and SP1
    Xi Wu et al, 2016, Proceedings of the National Academy of Sciences CrossRef
  8. Turning Tumors into Vaccines: Co-opting the Innate Immune System
    Jasper G. van den Boorn et al, 2013, Immunity CrossRef
  9. 14-3-3σ Contributes to Radioresistance By Regulating DNA Repair and Cell Cycle via PARP1 and CHK2
    Yifan Chen et al, 2017, Molecular Cancer Research CrossRef
  10. Differential impact of cytoplasmic vs. nuclear RAD51 expression on breast cancer progression and patient prognosis
    Yen-Yun Wang et al, 2023, International Journal of Oncology CrossRef
  11. Ellagic Acid Enhances Apoptotic Sensitivity of Breast Cancer Cells to γ-Radiation
    Vidhula Ahire et al, 2017, Nutrition and Cancer CrossRef
  12. The related miRNAs involved in doxorubicin resistance or sensitivity of various cancers: an update
    Zahra Torki et al, 2021, Cancer Chemotherapy and Pharmacology CrossRef